Kidney Tumours and Acute Renal Conditions

ANZUNS presents a webinar on the management of kidney tumours, including discussion on acute renal conditions. This webinar is part of the 2021 ANZUNS Education Series, sponsored by Ipsen.

Registration for this webinar is FREE for ANZUNS members. Registration closes on 29 August 2021.

 

Our speakers:

Dr. Bishoy Hanna  Urology Registrar
Causes and management of hydronephrosis and pyelonephritis

Bishoy is a Urology Registrar at Nepean Hospital in Kingswood, New South Wales. He completed his undergraduate study at the University of Sydney in Medical Sciences before travelling to Melbourne for his MD at Melbourne University. Dr Hanna has worked in both tertiary metropolitan and smaller regional hospitals throughout New South Wales. He holds a Conjoint Fellow position at the University of Newcastle, has published and presented his research locally and internationally with a focus on multimedia in robotic surgery. Bish will be presenting about the causes and management of hydronephrosis and pyelonephritis.

Dr. Rick Catterwell  Urological Surgeon
Diagnosis and surgical management of kidney tumours

Rick Catterwell is a consultant Urologist working in South Australia in both public and in private practice. His specialist interests include robotic assisted upper tract and lower tract oncology, management of BPH, prostatic diagnostics and management of complex urolithiasis including PCNL.

In his spare time Rick loves watching the Adelaide Crows play footy.

Rick will be presenting about the diagnosis and surgical management of kidney tumours.

Assoc. Prof. Craig Gedye  Medical Oncologist, Cancer Researcher
Advanced kidney cancer - from zero to combo

Craig is a Medical Oncologist and Cancer Researcher. He works for people with melanoma, brain, prostate, bladder and kidney cancers at the Calvary Mater Newcastle, and is the Director of the HMRI Clinical Trials Unit.

His research focuses on complexity and heterogeneity in cancer – why are cancers different between different people; why are cancers cells different to each other; what does this mean for each person’s treatment? This challenging problem spans projects across the research spectrum, from patient experience, through clinical trials, translational biomarkers and questions in basic science.

Craig is privileged to lead several national cancer clinical trials for the ANZUP and COGNO cancer trials groups, chairs the ANZUP Renal Cancer Subcommittee, and is a member of the Mark Hughes Scientific Advisory Committee, HNEHLD Clinical Trials Ethics Subcommittee, COGNO Scientific Advisory Committee and ANZUP Cancer Trials Scientific Advisory Committee.

This webinar will be moderated by Kath Schubach, ANZUNS President.

Use the link below to register.Limited spots available.

By registering to this webinar, you agree that your contact details may be shared to our webinar sponsor for future correspondence.